Evaluation of efficacy of Akashavalli in Non- Alcoholic Fatty Liver Disease.
Phase 3
- Conditions
- Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
- Registration Number
- CTRI/2023/04/051865
- Lead Sponsor
- All India Institute of Ayurveda, New DelhiAll India Institute of Ayurveda, New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients diagnosed with Non- Alcoholic Fatty Liver Disease (NAFLD) Grade I and II.
Exclusion Criteria
Known cases of diabetes mellitus, hypertension, thyroid dysfunctions.
Known cases of any dysfunction of liver besides NAFLD like viral hepatitis, liver parenchymal disease, ascites, portal hypertension , hepato-cellular carcinoma, and liver transplantation or any condition interfering with the result of the treatment.
Alcoholic fatty liver disease patient.
Prior treatment with any medicine which affects the treatment of non-alcoholic fatty liver disease within 3 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in the Ultrasonography (USG) findings from Grade II to Grade I and from Grade I towards normal USG findings.Timepoint: 1 month trial followed by 1 month follow up
- Secondary Outcome Measures
Name Time Method Improvement in Liver function tests and clinical presentation of patient.Timepoint: 1 month trial followed by 1 month follow up